The Florida Market
Florida is the third-largest state economy and a rapidly growing market for Pharmaceuticals & Life Sciences technology — with a regulatory environment that includes the Florida Digital Bill of Rights, sector-specific state licensing requirements, and the compliance obligations of serving one of the country's largest elderly and Medicare-dependent populations.
Pharmaceuticals & Life Sciences organizations in Florida operate in a market with active state regulatory enforcement across financial services (OFR), healthcare (AHCA), and consumer protection (AG's office). Engineering teams serving Florida need current Florida-specific regulatory knowledge — not federal baseline compliance with Florida assumed to follow.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Florida is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Florida. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Florida. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Florida. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.